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The incidence of patients with end-stage
renal failure and type 2 diabetes mellitus as a comorbid
condition has increased progressively in the past
decades. Causes of renal disease might vary from one
population to another.
The aim of this study was to know the characteristics of the
diabetic patients on regular dialysis at Al-noor Specialist
Hospital, Makkah, SaudiArabia.
The data had been collected
retrospectively in the month of Shawal 1425
corresponding to 13-11-2004----12-12-2004 from the
diabetic patients directly that were on dialysis due to end
stage renal disease (ESRD) and from their files.
: The mean age of Diabetics was (55.2years)
showing male predominance 31(60.8%). All were
Saudies. The mean duration of Diabetes mellitus &
dialysis were (16.8years) and (22months), respectively.
The mean age of start of Diabetes mellitus & dialysis was
(37.4 years) & (53.5 years). The mean duration of onset of
diabetes to dialysis was (16.1 years). Out of the total,
29(56.9%) were non-smoker. Patients with family H/O
diabetes with other associated illnesses were 23(45%)
followed by 15(29.4%) had family H/O only diabetes. Type
II diabetics were 40(78.4%). Regarding metabolic profile,
patients with high blood glucose level were 10(19.6%)
while 3(5.9%), 50(98%) & 18(35.3%) patients had high
cholesterol, low density lipoprotein & triglyceride levels,
respectively.
Maximum patients were in sixth decade of
life. Up to three fourth patients had family H/O diabetes.
Most of the subjects had only diabetic nephropathy.
Maximum patients had high low density lipoprotein level.
Dialysis was main treatment to control diabetes.
Diabetes mellitus, dialysis, ESRD, diabetic
nephropathy.
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Introduction
The incidence of patients with end-stage renal failure and
type 2 diabetes mellitus as a comorbid condition has
increased progressively in the past decades, first in the
United States and Japan, but subsequently in all countries
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with a western lifestyle. Causes of renal disease might
vary from one population to another.e.g. in Saudi
Arabia, renal disease had been reported to be relatively
high and was thought probably to be due to a cultural
practice that might increase the incidence of genetic
renal disease, that was, the intermarriage among
cousins and other close relatives similarly other factors
of renal disease include hypertension, chronic
glomerulonephritis, diabetes, and kidney stones. The
prevalence of diabetes mellitus (DM) caused heavy
economical burden to health-care providers, the annual
mortality among dialysis patients remained high,
reaching 22% in USA, 14.4% in Europe, and 11% in
Saudi Arabia. There was no data available on the
incidence of diabetic renal disease in Saudi diabetics. It
was known that vast majorityof Saudi diabetics entering
dialysis (96%) were of Type II. In Saudi Arabia DM
increased from 4.9% in 1985 to 7.4% in 1995, there
were 700 patients on hemodialysis at the end of 2001,
the annual rate of increase in number of these patients
was 9.7% and it was projected that by the year of 2015
there will be more than 13,000 patients on dialysis in
Kingdom.
In this article we have studied the clinical profile of
diabetic patients with ESRD undergoing hemodialysis
at theAl-noor Specialist Hospital, Makkah, with a view of
identifying common clinical factors.
This descriptive study was done in the nephrology unit
ofAl-noor specialist hospital; it is a teaching tertiary care
referral hospital in the Makkah region, Saudi Arabia. Its
dialysis unit had been established on 1409hijra (1989),
and started with only seven dialysis machines but now
has eighty-one. The data had been collected in the
month of Shawal of 1425hijra (corresponding to 13-11-
2004----12-12-2004), from patients' files, dialysis charts
and also from diabetic patients directly, who were on
regular dialysis treatment.
Medical files and dialysis charts were reviewed for
Socio-demographic data, duration of illnesses and
clinical profile of subjects with associated macro-
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peripheral vascular disease, gastrointestinal i.e.
gastropareses and diarrhoea, dermatological and
genitourinary dysfunctions i.e. uropathy and sexual
dysfunction and micro-vascular (eye i.e. retinopathy,
macular edema, cataract, glaucoma, and neuropathy and
nephropathy) complications. Subjects' age groups were
divided into decades. At the time of study, latest values of
glucose level lipid profile were collected from record.
Blood sugar (random) level, total cholesterol level, low
density lipoprotein level and triglyceride level, 200mg/dl,
200mg/dl, 130mg/dl and 165mg/dl respectively were
considered as high The information about History of
smoking, family history and anti diabetic treatment had
been collected from patients directly.
Similarly type of diabetes had also been confirmed by
inquiring from patients the age of diagnosis of diabetes as
well as mode of treatment started at the time of diagnosis
and current medication at the time of data collection. The
whole data had been analyzed manually to show the age
of onset of diabetes as well as dialysis, duration of
diabetes as well as dialysis, and the time spent from start
of diabetes to dialysis.
Simple Chi-squared test was applied to nominal, ordinal
and binary categorical data. Measurement data was
subjected to descriptive analysis as well as two sample t-
Test assuming equal variance to find significance of
difference in mean values of metabolic profile between
two sexes. P-value 0.05 was considered significant.
Total of 253 patients with ESRD was on regular dialysis in
the study period. Out of them 57(22.5%) were diabetic
. Six diabetics were pulled out from
study because four had lack of follow up, one was expired
and one had lack of required data. Males were 31(60.8%)
and all were Saudis. Maximum patients 23(45.1%) were
in 6 decade of life. Non-smokers were 29(56.9%).Almost
38(74.5%) patients had family H/O diabetes
In Table I, most of the subjects 23(45.1%) developed
diabetes mellitus in 4 decade of life (mean=37.4 SD1.6).
Thirty six (70.6%) were belonged to 11-20 years of
duration of diabetes mellitus (mean=16.8 SD0.83).
Mostly patients 22(43.1%) developed ESRD requiring
dialysis in 6 decade of life (mean=53.5 SD1.7). More
than half of subjects 36(70.6%) had duration of dialysis
24 months (mean=22 SD2.4). Eighteen (35.3%)
patients developed dialysis after 16-20 years of diabetes
(mean=16.1 SD1.5). No patient was on dialysis more
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27(52.9%) subjects had only diabetic nephropathy
without any other complications. Patients of Type 11 DM
were (78.4%). Only one male patient had low density
lipoprotein (LDL) level <130mg/dl while 41(80%) had
glucose level <200mg/dl. Dialysis was the only
management of diabetic control in 30(58.8%) patients.
Discussion
End-stage renal failure requiring dialysis is one of the
most serious complications of diabetes mellitus, and
diabetes is the most common cause of end-stage renal
failure. The average annual incidence rate of dialysis was
12 times greater in persons with diabetes than without
diabetes. By 1999-2000, diabetic patients comprised
51% of the incident dialysis population. The average
annual prevalence rate was 10 times greater in the
diabetic cohort. Patients with diabetes had more co-
morbidity at the start of dialysis and poorer three year
survival (55 vs. 68%; P < 0.0001). The incident and
prevalent rates of dialysis for patients with diabetes
mellitus are many times the rates of those without
diabetes. Patients with diabetes mellitus often start
dialysis with significant co-morbidities, which may
contribute to the relatively high rate of mortality on
dialysis. A number of cross-sectional studies have
confirmed that the susceptibility to ESRD due to non-
diabetic renal disease is increased in subjects of African
and Indo-Asian descent.
In our unit during the study period 253 patients were on
dialysis while in 1982, according to Jondeby, there were
370 patients receiving dialysis in KSA,in 1999 the number
increased to 5706, with 2084 new patients entering
dialysis in 1999 alone. Themean age increased from 37.9
to 51.3 years, respectively. In the early 1980s, Jondeby
reportedDM as a cause of end-stage renal disease in only
(4%) of the patients but in our unit (22.5%) patients
developed ESRD due to DM also contrary to Qari,
Brazda12 and al-Muhanna but Foucan showed it
(22%) and El-Rashaid had shown (21.1%).
Of all diabetics entering dialysis, non-insulin dependent
DM accounted for (78.4%) in our unit compared to (96%)
in the study of Ismail and Sunagawa while Brazda had
shown (28.6%).  Our study showed male predominance
similar to the studies of Qari , Sunagawa and Whorra  ,
but contrary to the study of Foucani.
Hypertension was a most common comorbid stat in our
study like in studies of Choi & Perneger Type 2
diabetes and hypertension are commonly associated
conditions, both of which carry an increased risk of
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hypertension in type2 diabetes is higher than that in the
general population, especially in younger patients.
Hypertension increases the already high risk of
cardiovascular disease associated with type 2
diabetes. Another factor was that there is diminishing
mortality from hypertension and cardiovascular causes,
so that patients survive long enough to develop
nephropathy and end-stage renal failure.
The mean age of diabetic patients in our study is more
than those of Qari and Ma  . Similarly mean duration of
dialysis in our study was (22.1 months) which was
higher than those of Ma  , Qari and Whorra. The mean
age of start of dialysis in our study was lesser than that
of Qari (46.5yrs) and Foucan  (60.6yrs). Our study also
had shown prominent dyslipidemia. It is noted that out
of the study group, (71.2%) had been started on
heamodialysis within sixteen to twenty years of being
diagnosed to have diabetes, suggesting either a delay
in the diagnosis of disease or the presence of other
factors leading to acceleration of diabetic nephropathy
like dyslipidemia, hypertension.
The prevalence of both acute and chronic renal failure is
high in the Arab world. Data available on the exact
prevalence of various renal diseases are very limited.
Nevertheless, the reported prevalence of chronic renal
failure is 80 to 120 per million populations (pmp) in the
Kingdom of Saudi Arabia and 225 pmp in Egypt. This is
in comparison with the reported prevalence of 283 pmp
in Europe, 975 pmp in the United States, and 1149 pmp
in Japan. Lower prevalence rates reported in this region
could be due to underreporting. Paradoxically, in the
Arab world, we have a good opportunity to reduce the
incidence of kidney failure (chronic and acute) because
many of the causes of renal failure are eminently
preventable. It is worthy of mention that, in the Arab
world, the budget for research is about 0.15% of the
national domestic product compared with the
international average of (1.5%).
This study was limited to hospital based and had the
data of only diabetic patients who were on regular
haemodialysis since last three months of start of study.
Subjects who developed ESRD due to other reasons
were excluded. Other “umra” visitor patients who were
admitted for dialysis not on regular bases were also
excluded. Study duration is limited to only one month
which did not give picture of new cases. HbA1c which is
a good reflector of diabetes control could not be
measured. Latest glucose and lipid profile was
collected rather than to calculate the mean values of
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Age of start of diabetes (years) 36.1(14-58) 39.4(16-66)
Diabetes mellitus duration (years) 16(3-30) 18.2(7-30)
Age of start of dialysis (years) 52.4(21-74) 55.2(33-76)
Dialysis duration (months) 22(3-72) 21.9(3-60)




outcome of subjects were not followed as more
complications occurred due to catheterization which
could worse the condition.
In conclusion, diabetes is an important cause of ESRD in
Saudi patients undergoing chronic HD at al-noor hospital.
This may be attributed to poor control of diabetes,
hypertension as well as inadequate early screening.
Conclusion
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Improved care of diabetes and aggressive management
of hypertension with good follow up on out patient bases
can reduce or delay prevalence and improve good
prognosis of diabetic nephropathy.
This report confirms the association of DM with ESRD
and other micro & macro vascular complications, and
also the enhancing factors, which are responsible for
ESRD due to diabetic nephropathy.
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